NASDAQ:UBIO - ProShares UltraPro NASDAQ Biotechnology Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ProShares UltraPro NASDAQ Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $33.00 -1.56 (-4.51 %) (As of 02/20/2020 12:09 PM ET) Add Today's Range$33.00Now: $33.00▼$34.4750-Day Range$27.26MA: $31.83▼$33.9852-Week Range$17.05Now: $33.00▼$35.36Volume25,904 shsAverage Volume34,967 shsMarket Capitalization$24.75 millionP/E RatioN/ADividend Yield0.00%BetaN/A ProfileAdvanced ChartInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Basic Details Issuer ProShares Fund NameProShares UltraPro NASDAQ Biotechnology Tax ClassificationRegulated Investment Company SymbolNASDAQ:UBIO Inception Date6/22/2015 Fund ManagerMichael Neches, Tarak Dave WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$27.06 million Average Daily Volume$58,712.30 Discount/Premium-0.04% ETF Expenses Management Fee0.75% Other Expenses0.57% Total Expenses1.32% Fee Waiver-0.37% Net Expenses0.95%Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. Trustee Lead Market MakerVirtu Financial Receive UBIO News and Ratings via Email Sign-up to receive the latest news and ratings for UBIO and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:UBIO Rates by TradingView ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO) Frequently Asked Questions What is ProShares UltraPro NASDAQ Biotechnology's stock symbol? ProShares UltraPro NASDAQ Biotechnology trades on the NASDAQ under the ticker symbol "UBIO." Has ProShares UltraPro NASDAQ Biotechnology been receiving favorable news coverage? Press coverage about UBIO stock has trended very negative on Thursday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ProShares UltraPro NASDAQ Biotechnology earned a news sentiment score of -3.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for ProShares UltraPro NASDAQ Biotechnology. What other stocks do shareholders of ProShares UltraPro NASDAQ Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro NASDAQ Biotechnology investors own include Energous (WATT), Shopify (SHOP), Amarantus Bioscience (AMBS), NVIDIA (NVDA), Markel (MKL), Square (SQ), Adobe (ADBE), Baidu (BIDU), Booking (BKNG) and WisdomTree Japan Hedged SmallCap Equity Fund (DXJS). Who are ProShares UltraPro NASDAQ Biotechnology's major shareholders? ProShares UltraPro NASDAQ Biotechnology's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Jane Street Group LLC (7.53%) and Tower Research Capital LLC TRC (0.68%). Which major investors are selling ProShares UltraPro NASDAQ Biotechnology stock? UBIO stock was sold by a variety of institutional investors in the last quarter, including Tower Research Capital LLC TRC . Which major investors are buying ProShares UltraPro NASDAQ Biotechnology stock? UBIO stock was bought by a variety of institutional investors in the last quarter, including Jane Street Group LLC. How do I buy shares of ProShares UltraPro NASDAQ Biotechnology? Shares of UBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is ProShares UltraPro NASDAQ Biotechnology's stock price today? One share of UBIO stock can currently be purchased for approximately $33.00. How big of a company is ProShares UltraPro NASDAQ Biotechnology? ProShares UltraPro NASDAQ Biotechnology has a market capitalization of $24.75 million. View Additional Information About ProShares UltraPro NASDAQ Biotechnology. MarketBeat Community Rating for ProShares UltraPro NASDAQ Biotechnology (NASDAQ UBIO)Community Ranking: 1.7 out of 5 ()Outperform Votes: 54 (Vote Outperform)Underperform Votes: 103 (Vote Underperform)Total Votes: 157MarketBeat's community ratings are surveys of what our community members think about ProShares UltraPro NASDAQ Biotechnology and other stocks. Vote "Outperform" if you believe UBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UBIO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/20/2020 by MarketBeat.com StaffFeatured Article: How are dividend achievers different from dividend aristocrats?
